SCRIPSAMERICA CONTRACTS WITH CLEMENTI & ASSOCIATES LTD FOR FDA DRUG SUBMISSION

FOR IMMEDIATE RELEASE
(Free-Press-Release.com) January 5, 2011 --

January 5, 2011 Langhorne PA. ScripsAmerica today announced the signing of an agreement with Conshohocken PA-based Clementi and Associates, Ltd. Quoting from Clementi's own web site, Bob Schneiderman ScripsAmerica's CEO stated, "Planning and communicating among in-house project teams to regulatory consultants are required disciplines. Since we target the small to mid-size companies, our regulatory plans for dossiers submission are value-added for our clients. We know how to implement the plans we have crafted. Our approach to FDA interaction has always been and continues to be open, consistent and meaningful dialog. Clementi Associates keeps you and the FDA on "the same page", especially at critical meetings and at the time of approval commitments. Knowing the Division's rules is a must to keep your program on track.” Schneiderman further stated, "With their help and guidance we feel confident that we will be able to accomplish our goals in a timely fashion".


About ScripsAmerica

ScripsAmerica is a Delaware corporation, organized to supply Prescription and Neutraceutical drugs to distribution centers, hospitals, nursing homes, and end users. This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, among others, the potential for additional customer growth from acquired operations and additional opportunities for growth. There are important factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements, including: general economic business conditions, unfavorable weather conditions, the success of certain cost containment initiatives, changes in regulations or regulatory treatment, availability and the cost of capital, the success of growth initiatives, and other factors discussed in our filings with the Securities and Exchange Commissions. Additionally, this release may not be considered as legal, accounting, or investment advice, and is not, and may not be considered, a solicitation for the purchase of any securities issued by ScripsAmerica, Inc.

For more information about ScripsAmerica:
Steve Urbanski
800-957-7622 ext 102

About Clementi & Associates, Ltd

Since 1990, Clementi & Associates, Ltd has focused solely on medical and regulatory affairs including drug and device submissions, content reviews and risk assessments. Clementi & Associates, Ltd is committed to understanding reform of the FD&C Act, PDUFA, FDAAA, and other reforms, and assessing the impact reform will have on drug development and commercialization. Clementi & Associates, Ltd is a full service provider of global regulatory and medical services, working with the small to medium- size company to transform good science into medically useful and commercially viable new products.


For more information about Clementi & Associated Ltd:
Clementi & Associates, Ltd
www.regulatoryaffairs.com
Tel: 610-977-2089

CONSULTING     FDA Approval     FDA Certification     generic pharmaceutical     Generics Drug     medical     pharmaceutical distributor     pharmaceutical sector